ULTRABCD: Physical and Cellular Effects of Ultra-cycling

Sponsor
Azienda Ospedaliera Universitaria Integrata Verona (Other)
Overall Status
Completed
CT.gov ID
NCT05424588
Collaborator
Dr. Michele Braggio (Other), Dr.ssa Maria Teresa Valenti (Other), Dr.ssa Arianna Minoia (Other), Dr. Gianluigi Dorelli (Other), Dr. Mattia Cominacini (Other), Prof. Francesco Bertoldo (Other), Dr.ssa Jessica Bertacco (Other), Dr.ssa Tonia De Simone (Other), Prof.ssa Maria Grazia Romanelli (Other), Prof.ssa Monica Mottes (Other), Dr.ssa Lekhana Bhandary (Other)
8
1
12.3
0.6

Study Details

Study Description

Brief Summary

Background: NorthCape4000 (NC4000) is the most participated ultra-endurance cycling race.

Eight healthy male Caucasian amateur cyclists were evaluated: a) before starting the preparation period; b) in the week preceding NC4000 (after the training period); c) after NC4000 race, with the aim to identify the effects of ultra-cycling on body composition, aerobic capacity and biochemical parameters as well as on the differentiation of progenitor cells.

Methods: Bioelectrical impedance analysis (BIA) and dual energy x-ray absorptiometry (DEXA) assessed body composition; cardiopulmonary exercise test (CPET) evaluated aerobic capacity. Differentiation of circulating progenitor cells was evaluated by analyzing the modulation in the expression of relevant transcription factors. In addition, in vitro experiments were performed to investigate the effects of sera of NC4000 participants on adipogenesis and myogenesis. The effects of NC4000 sera on Sestrins and Sirtuin modulation and the promotion of brown adipogenesis in progenitor cells was investigated as well. Two-tailed Student's paired-test was used to perform statistical analyses.

Results: We observed fat mass decrease after training as well as after NC4000 performance; we also recorded that vitamin D and lipid profiles were affected by ultra-cycling. In addition, our findings demonstrated that post-NC4000 participant's pooled sera exerted a positive effect in stimulating myogenesis and in inducing brown adipogenesis in progenitor cells.

Conclusions: The training program and Ultra-cycling lead to beneficial effects on body composition and biochemical lipid parameters, as well as changes in differentiation of progenitor cells , with significant increases in brown adipogenesis and in MYOD levels.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: clinical evaluation, bioelectrical impedance analysis (BIA), cardiopulmonary exercise testing (CPET) and venipuncture for blood samples collection

Study Design

Study Type:
Observational
Actual Enrollment :
8 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Effects of a 4400 km Ultra-cycling Non-competitive Race and Related Training on Body Composition and Circulating Progenitors Differentiation
Actual Study Start Date :
Dec 21, 2020
Actual Primary Completion Date :
Sep 7, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Healthy male amateur Caucasian cyclists

Healthy male amateur Caucasian cyclists who attended the NC4000 4th edition underwent clinical evaluation, bioelectrical impedance analysis (BIA), cardiopulmonary exercise testing (CPET) and venipuncture for blood samples collection.

Diagnostic Test: clinical evaluation, bioelectrical impedance analysis (BIA), cardiopulmonary exercise testing (CPET) and venipuncture for blood samples collection
Total body dual-energy X-ray absorptiometry (DEXA) was taken BN and AN to measure total (FM) and segmental fat (truncal FM), visceral adipose tissue (VAT) and lean mass (LM). Tetra-polar dual frequency BIA (InBody 120; Cerritos, USA) was used BPP, BN and AN to measure weight and to estimate FM, FFM, and MM. Impedance measurements were performed. CPET was carried out on a cycle ergometer with clip-on pedals. Blood samples were collected in the morning BPP, BN, AN. Biochemical parameters considered in this study were: ALT, AST, creatinine, 25-hydroxy vitamin D, total cholesterol, HDL, LDL, triglycerides concentrations. We isolated CPCs from heparinized blood, as previously reported (14). After the collection of peripheral blood mononuclear cells (PBMCs) by a gradient centrifugation. (15). Differentiating Human Skeletal muscle cells were cultured with or without pooled sera of participants at 5% final concentration. 146b and 34a miRNAs were extracted from PBMCs.

Outcome Measures

Primary Outcome Measures

  1. Body composition [DEC 2020-SEP 2021]

    Total body dual-energy X-ray absorptiometry (DEXA) was taken BN and AN to measure total (FM) and segmental fat (truncal FM), visceral adipose tissue (VAT) and lean mass (LM)

  2. Cell differentiation [DEC 2020-SEP 2021]

    possible association with commitment of circulating progenitors.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • male amateur Caucasian cyclists who attended the NC4000 4th edition
Exclusion Criteria:
  • any condition that might have altered performance or laboratory tests results

Contacts and Locations

Locations

Site City State Country Postal Code
1 AOUI Verona Italy 37134

Sponsors and Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona
  • Dr. Michele Braggio
  • Dr.ssa Maria Teresa Valenti
  • Dr.ssa Arianna Minoia
  • Dr. Gianluigi Dorelli
  • Dr. Mattia Cominacini
  • Prof. Francesco Bertoldo
  • Dr.ssa Jessica Bertacco
  • Dr.ssa Tonia De Simone
  • Prof.ssa Maria Grazia Romanelli
  • Prof.ssa Monica Mottes
  • Dr.ssa Lekhana Bhandary

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Luca Giuseppe Dalle Carbonare, Associate Professor, Azienda Ospedaliera Universitaria Integrata Verona
ClinicalTrials.gov Identifier:
NCT05424588
Other Study ID Numbers:
  • ULTRANORD
First Posted:
Jun 21, 2022
Last Update Posted:
Jun 21, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Luca Giuseppe Dalle Carbonare, Associate Professor, Azienda Ospedaliera Universitaria Integrata Verona

Study Results

No Results Posted as of Jun 21, 2022